Docetaxel plus androgen deprivation withdrawal may restore sensitivity to luteinizing hormone-releasing hormone analog therapy in castration-resistant prostate cancer patients

被引：3
作者：
Bedussi, Francesca [1 ,2 ]
Valcamonico, Francesca [1 ]
Mosca, Alessandra [3 ]
Sigala, Sandra [2 ]
Ferrari, Laura [1 ]
Terrone, Carlo [4 ]
Dalla Volta, Alberto [1 ]
Marchioro, Giansilvio [4 ]
Ferrari, Vittorio [1 ]
Alabiso, Oscar [3 ]
Memo, Maurizio [2 ]
Berruti, Alfredo [1 ]
机构：
[1] Univ Brescia, Dept Surg Radiol & Publ Hlth, Spedali Civili Brescia, Oncol Unit, Brescia, Italy
[2] Univ Brescia, Pharmacol Sect, Dept Mol & Translat Med, Brescia, Italy
[3] Univ Piemonte Orientale, Maggiore della Carita Univ Hosp, Med Oncol, Novara, Italy
[4] Univ Piemonte Orientale, Maggiore della Carita Univ Hosp, Urol, Novara, Italy
来源：
ENDOCRINE | 2016年 / 54卷 / 03期
关键词：
INCREASED SURVIVAL; MITOXANTRONE; PREDNISONE; ABIRATERONE; CHEMOTHERAPY; MECHANISMS;
D O I：
10.1007/s12020-015-0827-z
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：830 / 833
页数：4
相关论文
共 20 条
  • [1] Systemic Therapy in Men With Metastatic Castration-Resistant Prostate Cancer: American Society of Clinical Oncology and Cancer Care Ontario Clinical Practice Guideline
    Basch, Ethan
    Loblaw, D. Andrew
    Oliver, Thomas K.
    Carducci, Michael
    Chen, Ronald C.
    Frame, James N.
    Garrels, Kristina
    Hotte, Sebastien
    Kattan, Michael W.
    Raghavan, Derek
    Saad, Fred
    Taplin, Mary-Ellen
    Walker-Dilks, Cindy
    Williams, James
    Winquist, Eric
    Bennett, Charles L.
    Wootton, Ted
    Rumble, R. Bryan
    Dusetzina, Stacie B.
    Virgo, Katherine S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (30) : 3436 - U133
  • [2] Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: Updated survival in the TAX 327 study
    Berthold, Dominik R.
    Pond, Gregory R.
    Soban, Freidele
    de Wit, Ronald
    Eisenberger, Mario
    Tannock, Ian F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (02) : 242 - 245
  • [3] Taxane-Induced Blockade to Nuclear Accumulation of the Androgen Receptor Predicts Clinical Responses in Metastatic Prostate Cancer
    Darshan, Medha S.
    Loftus, Matthew S.
    Thadani-Mulero, Maria
    Levy, Benjamin P.
    Escuin, Daniel
    Zhou, Xi Kathy
    Gjyrezi, Ada
    Chanel-Vos, Chantal
    Shen, Ruoqian
    Tagawa, Scott T.
    Bander, Neil H.
    Nanus, David M.
    Giannakakou, Paraskevi
    [J]. CANCER RESEARCH, 2011, 71 (18) : 6019 - 6029
  • [4] Abiraterone and Increased Survival in Metastatic Prostate Cancer
    De Bono, Johann S.
    Logothetis, Christopher J.
    Molina, Arturo
    Fizazi, Karim
    North, Scott
    Chu, Luis
    Chi, Kim N.
    Jones, Robert J.
    Goodman, Oscar B., Jr.
    Saad, Fred
    Staffurth, John N.
    Mainwaring, Paul
    Harland, Stephen
    Flaig, Thomas W.
    Hutson, Thomas E.
    Cheng, Tina
    Patterson, Helen
    Hainsworth, John D.
    Ryan, Charles J.
    Sternberg, Cora N.
    Ellard, Susan L.
    Flechon, Aude
    Saleh, Mansoor
    Scholz, Mark
    Efstathiou, Eleni
    Zivi, Andrea
    Bianchini, Diletta
    Loriot, Yohann
    Chieffo, Nicole
    Thian Kheoh
    Haqq, Christopher M.
    Scher, Howard I.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (21) : 1995 - 2005
  • [5] Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
    de Bono, Johann Sebastian
    Oudard, Stephane
    Ozguroglu, Mustafa
    Hansen, Steinbjorn
    Machiels, Jean-Pascal
    Kocak, Ivo
    Gravis, Gwenaelle
    Bodrogi, Istvan
    Mackenzie, Mary J.
    Shen, Liji
    Roessner, Martin
    Gupta, Sunil
    Sartor, A. Oliver
    [J]. LANCET, 2010, 376 (9747) : 1147 - 1154
  • [6] Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
    Fizazi, Karim
    Scher, Howard I.
    Molina, Arturo
    Logothetis, Christopher J.
    Chi, Kim N.
    Jones, Robert J.
    Staffurth, John N.
    North, Scott
    Vogelzang, Nicholas J.
    Saad, Fred
    Mainwaring, Paul
    Harland, Stephen
    Goodman, Oscar B., Jr.
    Sternberg, Cora N.
    Li, Jin Hui
    Kheoh, Thian
    Haqq, Christopher M.
    de Bono, Johann S.
    [J]. LANCET ONCOLOGY, 2012, 13 (10) : 983 - 992
  • [7] Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion
    Harris, William P.
    Mostaghel, Elahe A.
    Nelson, Peter S.
    Montgomery, Bruce
    [J]. NATURE CLINICAL PRACTICE UROLOGY, 2009, 6 (02): : 76 - 85
  • [8] James N.D., 2015, ASCO 2015
  • [9] Microtubules as a target for anticancer drugs
    Jordan, MA
    Wilson, L
    [J]. NATURE REVIEWS CANCER, 2004, 4 (04) : 253 - 265
  • [10] Understanding the Mechanisms of Androgen Deprivation Resistance in Prostate Cancer at the Molecular Level
    Karantanos, Theodoros
    Evans, Christopher P.
    Tombal, Bertrand
    Thompson, Timothy C.
    Montironi, Rodolfo
    Isaacs, William B.
    [J]. EUROPEAN UROLOGY, 2015, 67 (03) : 470 - 479
12